-
1
-
-
0026689853
-
A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy
-
Bremer K for the Granisetron Study Group (1992) A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy. Eur J Cancer [A] 28:1018-1022
-
(1992)
Eur J Cancer [A]
, vol.28
, pp. 1018-1022
-
-
Bremer, K.1
-
2
-
-
0027973433
-
Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis
-
Carmichael J, Bessel EM, Harris AL, Hutcheon AW, Dawes PJDK, Daniels S (1994) Comparison of granisetron alone and granisetron plus dexamethasone in the prophylaxis of cytotoxic-induced emesis. Br J Cancer 70:1161-4
-
(1994)
Br J Cancer
, vol.70
, pp. 1161-1164
-
-
Carmichael, J.1
Bessel, E.M.2
Harris, A.L.3
Hutcheon, A.W.4
Dawes, P.J.D.K.5
Daniels, S.6
-
3
-
-
0027276219
-
The control of acute cisplatin-induced emesis - A comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone
-
Chevallier B (1993) The control of acute cisplatin-induced emesis - a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Br J Cancer 68:176-180
-
(1993)
Br J Cancer
, vol.68
, pp. 176-180
-
-
Chevallier, B.1
-
4
-
-
44049124053
-
Fractionated chemotherapy - Granisetron or conventional antiemetics?
-
Diehl V for the Granisetron Study Group (1992) Fractionated chemotherapy - granisetron or conventional antiemetics? Eur J Cancer [A] 28 [Suppl 1]:S21-S28
-
(1992)
Eur J Cancer [A]
, vol.28
, Issue.1 SUPPL.
-
-
Diehl, V.1
-
5
-
-
0027496381
-
Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy
-
Fox SM, Einhorn LH, Cox E, Powell N, Abdy A (1993) Ondansetron versus ondansetron, dexamethasone, and chlorpromazine in the prevention of nausea and vomiting associated with multiple-day cisplatin chemotherapy. J Clin Oncol 11:2391-2395
-
(1993)
J Clin Oncol
, vol.11
, pp. 2391-2395
-
-
Fox, S.M.1
Einhorn, L.H.2
Cox, E.3
Powell, N.4
Abdy, A.5
-
6
-
-
0025769394
-
The analysis of failure time data in crossover studies
-
France LA, Lewis JA, Kay R (1991) The analysis of failure time data in crossover studies. Statist Med 10:1099-1113
-
(1991)
Statist Med
, vol.10
, pp. 1099-1113
-
-
France, L.A.1
Lewis, J.A.2
Kay, R.3
-
7
-
-
0028100688
-
Oral granisetron alone and in combination with dexamethasone: A double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis
-
Heron JF, Goedhals L, Jordaan JP, Cunningham, Cedar J for the Granisetron Study Group (1994) Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. Ann Oncol 5:579-584
-
(1994)
Ann Oncol
, vol.5
, pp. 579-584
-
-
Heron, J.F.1
Goedhals, L.2
Jordaan, J.P.3
Cunningham4
Cedar, J.5
-
8
-
-
0030948336
-
Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer
-
Herrstedt J, Sigsgaard T, Handberg J, Schousboe BMB, Hansen M, Dombernowsky P (1997) Randomized, double-blind comparison of ondansetron versus ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer. J Clin Oncol 15:1690-1696
-
(1997)
J Clin Oncol
, vol.15
, pp. 1690-1696
-
-
Herrstedt, J.1
Sigsgaard, T.2
Handberg, J.3
Schousboe, B.M.B.4
Hansen, M.5
Dombernowsky, P.6
-
9
-
-
0027184255
-
Antiemetic therapy - Where do we go from here?
-
Kaye SB (1993) Antiemetic therapy - where do we go from here? Ann Oncol 4:443-445
-
(1993)
Ann Oncol
, vol.4
, pp. 443-445
-
-
Kaye, S.B.1
-
10
-
-
0019362251
-
Introduction to sample size determination and power analysis for clinical trials
-
Lachin JM (1981) Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 2:93-113
-
(1981)
Controlled Clin Trials
, vol.2
, pp. 93-113
-
-
Lachin, J.M.1
-
11
-
-
0029364511
-
Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
-
Latreille J, Stewart D, Laberge F, Hoskins P, Rusthoven J, McMurtrie E, et al (1995) Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy. Support Care Cancer 3:307-312
-
(1995)
Support Care Cancer
, vol.3
, pp. 307-312
-
-
Latreille, J.1
Stewart, D.2
Laberge, F.3
Hoskins, P.4
Rusthoven, J.5
McMurtrie, E.6
-
12
-
-
0025276963
-
Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease
-
Lund B, Hansen M, Hansen OP, Hansen HH (1990) Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease. J Clin Oncol 8:1226-1230
-
(1990)
J Clin Oncol
, vol.8
, pp. 1226-1230
-
-
Lund, B.1
Hansen, M.2
Hansen, O.P.3
Hansen, H.H.4
-
13
-
-
44049124434
-
A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic induced emesis
-
Marty M (1992) A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic induced emesis. Eur J Cancer [A] 28 [Suppl 4]:S12-S16
-
(1992)
Eur J Cancer [A]
, vol.28
, Issue.4 SUPPL.
-
-
Marty, M.1
-
14
-
-
0023101579
-
Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: A randomized double-blind trial of the Italien Oncology Group for Clinical Research
-
Roila F, Tonato M, Basurto C, Bella M, Passalacqua R, Morsia D, et al (1987) Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italien Oncology Group for Clinical Research. J Clin Oncol 5:141-149
-
(1987)
J Clin Oncol
, vol.5
, pp. 141-149
-
-
Roila, F.1
Tonato, M.2
Basurto, C.3
Bella, M.4
Passalacqua, R.5
Morsia, D.6
-
15
-
-
0027176140
-
The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days
-
The Granisetron Study Group (1993) The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in patients receiving fractionated chemotherapy over 5 days. J Cancer Res Clin Oncol 119:555-559
-
(1993)
J Cancer Res Clin Oncol
, vol.119
, pp. 555-559
-
-
-
16
-
-
0028888664
-
Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer
-
The Italian Group for Antiemetic Research (1995) Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332:1-5
-
(1995)
N Engl J Med
, vol.332
, pp. 1-5
-
-
-
17
-
-
0028432117
-
Antiemetics in cancer chemotherapy: Historical perspective and current state of the art
-
Tonato M, Roila F, Del Favero A, Ballatori E (1994) Antiemetics in cancer chemotherapy: historical perspective and current state of the art. Support Care Cancer 2:150-160
-
(1994)
Support Care Cancer
, vol.2
, pp. 150-160
-
-
Tonato, M.1
Roila, F.2
Del Favero, A.3
Ballatori, E.4
|